Vomiting: Clinical Trials

121 trials for Vomiting, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

121 completed. 121 Phase 2, 17 Phase 3, 9 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2121Completed 121
Phase 317Completed 17
Phase 19Completed 9

Follow Vomiting: new trials by email Literature Review of Vomiting trials Research Report on Vomiting

Trials (filtered) newest first · largest first

All 121 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Midazolam Adjunct Therapy for Prevention of PONV in Gynecological Laparoscopy
Midazolam 0.05 mg/kg IV as adjunct to dexamethasone and ondansetron for PONV prevention - Postoperative Nausea and Vomiting (PONV), Gynecological Laparoscopic Surgery
Phase 2CompletedHameed Latif Hospital, Lahore3002025-12-022026-06-25
A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use
Tradipitant, Placebo - Obesity
Phase 2CompletedVanda Pharmaceuticals1242025-02-252025-11-12
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.
CIN-102 Dose 15mg, Placebo, CIN-102 Dose 10mg - Idiopathic Gastroparesis
Phase 2CompletedCinDome Pharma, Inc.4162025-01-292026-07-13
Effect of Magnesium Sulfate on Hemodynamics on Laparoscopic Cholecystectomy Patients
Placebo, Magnesium - Hemodynamics Instability, Pain After Surgery
Phase 1 / Phase 2CompletedZiauddin University602025-01-062026-09-02
PONV Prevention Via Percutaneous Nerve Electrical Stimulation on PC6
electrical stimualtion via EmeTerm bracelet, antimetic drugs( dexamethasone,ondansetron) - Postoperative Nausea and Vomiting
Phase 2CompletedPeking Union Medical College Hospital3262024-02-052026-06-17
Prevention of Post-Operative Nausea and Vomiting With Propofol Infusion
Hybrid anesthesia (propofol + sevoflurane), Propofol only TIVA - Post-operative Nausea and Vomiting
Phase 2CompletedMilton S. Hershey Medical Center652024-02-012026-08-14
The Efficacy of B6 and Metoclopramide Combination in Comparison With the Other Antiemetics
Metoclopramide and Vitamin B6, Vitamin B6, Ondansetron - Vomiting
Phase 2 / Phase 3CompletedUniversity of Baghdad2502024-01-302024-04-30
Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients
Amisulpride Injection, Dexamethasone - Nausea and Vomiting, Postoperative
Phase 2 / Phase 3CompletedAcacia Pharma Ltd4532024-01-182025-06-25
Dexamethasone at Night vs at Induction on PONV After Laparoscopic Cholecystectomy
At-night Dexamethasone, At-induction Dexamethasone - Postoperative Nausea and Vomiting, Postoperative Pain
Phase 2 / Phase 3CompletedMansoura University602023-10-082024-01-25
Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation
Glycopyrrolate, Anisodamine - Nausea and Vomiting
Phase 1 / Phase 2CompletedJie Chen1302023-10-012024-09-05
The Impact of Preoperative Olanzapine on Quality of Recovery After Discharge From Ambulatory Surgery
Olanzapine, Placebo - Postoperative Nausea and Vomiting
Phase 2CompletedYale University3982023-06-262026-07-16
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis
CIN-102 Dose 15mg or 10mg, Placebo - Diabetic Gastroparesis
Phase 2CompletedCinDome Pharma, Inc.3822023-03-272026-11-05
Baclofen in Preventing Postoperative Nausea and Vomiting After Bariatric Surgery
Baclofen Tablets - Postoperative Nausea and Vomiting, Laparoscopic Sleeve Gastrectomy
Phase 2 / Phase 3CompletedTanta University1002022-08-222025-04-22
Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV)
Standard of Care Treatment for Chemotherapy Induced Nausea and Vomiting (CINV), Aromatherapy Care - Chemotherapy-induced Nausea and Vomiting
Phase 2CompletedUniversity of Miami1002022-08-012025-04-17
Capsaicin Cream as an Adjunctive Therapy for Nausea and Vomiting of Pregnancy
Capsaicin Topical Cream, Metoclopramide, Ondansetron - Hyperemesis Gravidarum, Nausea Gravidarum
Phase 2CompletedWomen and Infants Hospital of Rhode Island302022-05-242024-02-07
Protreat-Trial: Prophylactic Antiemetic Treatment of Opioid-induced Nausea and Vomiting (OINV) in Palliative Care
Palonosetron Hydrochloride, Placebo - Nausea, Vomiting
Phase 2CompletedGerhild Becker302022-05-032025-03-19
Use of Aromatherapy to Reduce Symptom Burden
Essential oils, Placebo - Anxiety, Chemotherapy-induced Nausea and Vomiting
Phase 2CompletedIndiana University922022-03-072024-05-16
Postoperative Analgesic Effectiveness of Bupivacaine With and Without Dexmedetomidine in Patients With Abdominal Surgery
bupivacaine wound infilteration, Bupivacaine plus dexmedetomidine wound infilteration - Post Operative Pain, Bradycardia
Phase 2 / Phase 3CompletedSahiwal medical college sahiwal642022-02-202024-08-01
Supplemental Perioperative Intravenous Crystalloids for Postoperative Nausea and Vomiting in Children Undergoing Oncological Surgery
Ringer's Lactate, normal Saline - Nausea and Vomiting, Postoperative
Phase 2 / Phase 3CompletedAlexandria University1002022-01-102022-12-20
Olanzapine for the Prevention of Postoperative Nausea and Vomiting
Placebo, 5 mg Olanzapine Tablets, 10 mg Olanzapine Tablets - Postoperative Nausea
Phase 1 / Phase 2CompletedAmani Hassan Abdel-Wahab1322021-03-152023-03-09

Showing 20 of 121. Sign in to see all of them.

Narrower conditions

Nausea (65)  ·  Postoperative Nausea and Vomiting (41)  ·  Pain, Postoperative (8)  ·  Abdominal Pain (5)  ·  Gastroparesis (5)  ·  Neoplasms (5)  ·  Breast Neoplasms (4)  ·  Pain (4)  ·  Colonic Neoplasms (3)  ·  Diarrhea (3)  ·  Fever (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Bile Duct Neoplasms (2)  ·  Colorectal Neoplasms (2)

Broader conditions

Pathological Conditions, Signs and Symptoms (121)  ·  Signs and Symptoms (121)  ·  Signs and Symptoms, Digestive (121)  ·  Pathologic Processes (46)  ·  Postoperative Complications (43)  ·  Nausea (32)  ·  Neurologic Manifestations (19)  ·  Neoplasms (16)  ·  Neoplasms by Site (13)  ·  Digestive System Diseases (12)  ·  Pain (12)  ·  Gastrointestinal Diseases (10)  ·  Neoplasms by Histologic Type (9)  ·  Urogenital Diseases (8)

Interventions

Ondansetron (24)  ·  Aprepitant (15)  ·  Dexamethasone (14)  ·  Palonosetron (14)  ·  Olanzapine (8)  ·  ginger extract (7)  ·  Granisetron (5)  ·  Calcium Dobesilate (4)  ·  Saline Solution (4)  ·  Acupuncture Therapy (3)  ·  Metoclopramide (3)  ·  Ringer's Lactate (3)  ·  casopitant (3)  ·  netupitant (3)  ·  Fluorouracil (2)

Sponsors

GlaxoSmithKline (6)  ·  Acacia Pharma Ltd (4)  ·  M.D. Anderson Cancer Center (4)  ·  Assiut University (2)  ·  CinDome Pharma, Inc. (2)  ·  Clinica Universidad de Navarra, Universidad de Navarra (2)  ·  Eisai Inc. (2)  ·  Gary Morrow (2)  ·  Indiana University (2)  ·  Instituto do Cancer do Estado de São Paulo (2)  ·  Merck Sharp & Dohme LLC (2)  ·  Milton S. Hershey Medical Center (2)  ·  National Institute of Hygiene and Epidemiology, Vietnam (2)  ·  The Hospital for Sick Children (2)  ·  Accenture (1)

Countries

United States (60)  ·  Canada (10)  ·  Germany (7)  ·  Egypt (6)  ·  China (5)  ·  Pakistan (5)  ·  Spain (5)  ·  United Kingdom (5)  ·  Belgium (4)  ·  Brazil (4)  ·  France (4)  ·  Hungary (4)  ·  India (4)  ·  Italy (4)  ·  Poland (4)

Top investigators

Jorge Cortes, MD (2)  ·  Lee Dupuis, RPh, PhD (2)  ·  Roger Chammas (2)  ·  A. Riaz, MD (1)  ·  Aaron P Hong, MD, FRCPC (1)  ·  Agop Y. Bedikian, MD (1)  ·  Alfonso Gurpide (1)  ·  Amani H Abdel-wahab, MD (1)  ·  Andrea Myers, MD (1)  ·  Anh D Dang, PhD. (1)  ·  Arne Johan Norheim, MD Doctor phD (1)  ·  Arthur Blackstock (1)  ·  Aya Moussa (1)

Results publications

PMID 34002866, PMID 12145072, PMID 12906958, PMID 15680647, PMID 16436839, PMID 17513629, PMID 19617379, PMID 19834961, PMID 20049561, PMID 20718754, PMID 21851346, PMID 22096279, PMID 22286518, PMID 22520120, PMID 22546895, PMID 22546966, PMID 22733373, PMID 23041302, PMID 23510951, PMID 23811424, PMID 23872464, PMID 23904932, PMID 24337621, PMID 24438599, PMID 24587006, PMID 24882606, PMID 25127659, PMID 25488303, PMID 25670522, PMID 25885838, PMID 26838019, PMID 27082959, PMID 27307177, PMID 27829428, PMID 28032216, PMID 28058142, PMID 28160217, PMID 28243404, PMID 28760384, PMID 28856448, PMID 29111115, PMID 30900392, PMID 31303716, PMID 31862004, PMID 32188417, PMID 32229754, PMID 32301137, PMID 32379269, PMID 33388382, PMID 33451591

NIH funding

2008 (1), 2009 (1), 2014 (1), 2019 (1), P30CA046592 (1), R01HD076313 (1), U01DK073974 (1), U01DK073975 (1), U01DK073983 (1), U01DK073985 (1), U01DK074007 (1), U01DK074008 (1), U01DK074035 (1), U10CA037420 (1)